ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "T cells"

  • Abstract Number: 1641 • 2013 ACR/ARHP Annual Meeting

    Bispecific Antibodies For Redirection Of Human Regulatory T Cells To Surface-Inducible Autoantigen La/SS-B

    Stefanie Koristka1, Marc Cartellieri2, Claudia Arndt2, Anja Feldmann2, Irene Michalk2, Claudia C. Bippes2, Nicole Berndt2, Anne Hermsdorf2, Slava Stamova2, Biji T. Kurien3, Robert Hal Scofield4, A. Darise Farris5, Judith A. James6, Holger Bartsch7 and Michael Bachmann2, 1Carl Gustav Carus TU-Dresden, Dresden, Germany, 2Inst. Immunology, Carl Gustav Carus TU-Dresden, Dresden, Germany, 3College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 5Arthritis & Immunology Program, Oklahoma Medical Research Foun, Oklahoma City, OK, 6Oklahoma Medical Research Foundation, Oklahoma City, OK, 7Inst. Immunol., Carl Gustav Carus TU-Dresden, Dresden, Germany

    Background/Purpose: Adoptive transfer of regulatory T cells (Tregs)  represents a promising strategy for treatment of auto- and alloimmunity. However, it is difficult to obtain therapeutically…
  • Abstract Number: 722 • 2013 ACR/ARHP Annual Meeting

    BAFF Promotes T Follicular Helper Cell Development and Germinal Center Generation In Mice

    Song Guo Zheng1, Maogeng Chen1, Qiang Li2 and William Stohl3, 1Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, 2University of Southern California Keck School of Medicine, Los Angeles, CA, 3Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: BAFF (B cell activating factor belonging to the TNF family) promotes B cells maturation in germinal center. The generation of germinal center depends on…
  • Abstract Number: 2411 • 2013 ACR/ARHP Annual Meeting

    The Peripheral Blood T Cell Repertoire Before The Clinical Onset Of Rheumatoid Arthritis – a Study Of Incident Cases and Controls

    Carl Turesson1, Ulf Bergström2, Edgars Grins3, Olle Melander4, Lennart Truedsson5, Lennart Jacobsson2 and Stefan Jovinge3, 1Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden, 4Unit of Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 5Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden

    Background/Purpose: Previous studies indicate that circulating antibodies may be detected in individuals who later develop rheumatoid arthritis (RA) years before onset, and T cells have…
  • Abstract Number: 1621 • 2013 ACR/ARHP Annual Meeting

    T Helper 17 Cells and Interferon Type I: Partners In Crime In SLE?

    Odilia B.J. Corneth1, Zana Brkic2, Cornelia G. van Helden-Meeuwsen3, Radboud J.E.M. Dolhain4, Naomi I. Maria3, Sandra M.J. Paulissen4, Nadine Davelaar5, Jan Piet van Hamburg5, Paul L. Van Daele3, Virgil A. Dalm2, Martin van Hagen3, Marjan A. Versnel2 and Erik Lubberts6, 1Rheumatology and Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 2Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 3Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 5Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 6Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose: A hallmark of systemic autoimmune diseases, such as systemic lupus erythematotsus (SLE), is the increased expression of interferon (IFN) type I inducible genes, the…
  • Abstract Number: 723 • 2013 ACR/ARHP Annual Meeting

    Abatacept Is Highly Effective At Inhibiting T Cell Priming and Induces a Unique Transcriptional Profile In CD4+ t Cells

    Agapitos Patakas1, Rui-Ru Ji2, William Weir3, Sean Connolly2, Steven G. Nadler2, James M. Brewer4, Iain B. McInnes4 and Paul Garside4, 1Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Department of Immunology and Inflammation, Bristol Myers Squibb Co. Research and Development, Princeton, NJ, 3Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom, 4Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Absence of co-stimulation in the presence of TCR-stimulation has been proposed to induce tolerance via deletion or anergy.    Abatacept is a CTLA-4-Ig molecule that…
  • Abstract Number: 2317 • 2013 ACR/ARHP Annual Meeting

    Impact of PVA Coated Nanoparticles On Cellular Viability and Functionality of Immune Cells Obtained From Healthy Donors and Patients With Rheumatoid Arthritis Or Osteoarthritis

    Cindy Strehl1, Timo Gaber1, Manuela Jakstadt1, Martin Hahne1, Saskia Schellmann1, Barbara Szostak1, Géraldine Coullerez2, Heinrich Hofmann2, Gerd Burmester3 and Frank Buttgereit4, 1Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 2Institute of Materials Powder Technology Laboratory, École polytechnique fédérale de Lausanne, Lausanne, Switzerland, 3Rheumatology and Clinical Immunology, Campus Mitte, Charite University Hospital, Berlin, Germany, 4Charité - Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Nanotechnology has developed into a key technology of the 21st century. Over the recent years, the number of nanotechnical products has received an enormous…
  • Abstract Number: 1156 • 2013 ACR/ARHP Annual Meeting

    Suppression Of Immune Responses and Joint Inflammation By Myeloid-Derived Suppressor Cells In a T Cell-Dependent Mouse Model Of Rheumatoid Arthritis

    Katalin Mikecz1, Julia Kurko1, Timea Ocsko1, Andras Vida1, Beata Tryniszewska1, Tibor A. Rauch1, Joel A. Block2, Robert S. Katz3, Anjali Nair2, Carla R. Scanzello4 and Tibor T. Glant1, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush Medical College, Chicago, IL, 4Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of innate immune cells with immunosuppressive properties. We previously identified MDSCs in the synovial fluid (SF)…
  • Abstract Number: 724 • 2013 ACR/ARHP Annual Meeting

    Dose-Dependent Suppression Of Cytokine Production From T Cells By a Novel Phosphoinositide 3-Kinase Delta Inhibitor

    Emily E. Way1, Kong Chen2, Kamal D. Puri3 and Jay K. Kolls2, 1Pediatric Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 3Gilead Sciences, Inc., Seattle, WA

    Background/Purpose: The use of specific cytokine inhibitors to treat inflammatory autoimmune conditions is common but typically utilizes monoclonal antibodies, fusion proteins, and other molecules whose…
  • Abstract Number: 2333 • 2012 ACR/ARHP Annual Meeting

    A Novel Subset of CD4 T Cells That Provides Help for Human Memory B Cell Responses

    Sang T. Kim, Jin Young Choi, Begona Lainez and Joseph E. Craft, Internal Medicine, Section of Rheumatology, Yale University School of Medicine, New Haven, CT

    Background/Purpose: Follicular helper T (Tfh) cells provide help to B cells in germinal centers (GCs) of secondary lymphoid organs (SLOs) following primary antigen (Ag) challenge,…
  • Abstract Number: 2323 • 2012 ACR/ARHP Annual Meeting

    A Genetic Polymorphism on New Zealand Black Chromosome 1 Is Associated with Abnormal Dendritic Cell Function Leading to Expansion of TH1, TH17 and T Follicular Helper (TFH) Cells

    Nafiseh Talaei1, Carolina Landolt-Marticorena2, Babak Noamani1, Evelyn Pau3, Nan-Hua Chang4 and Joan E. Wither5, 1Genetics and developmental biology, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2Rheumatology, University Health Network, Toronto, ON, Canada, 3Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 4Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 51E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: We have previously shown that B6 mice with an introgressed homozygous New Zealand Black chromosome (c) 1 interval (70 to 100 cM) develop high titres…
  • Abstract Number: 1195 • 2012 ACR/ARHP Annual Meeting

    Identification of Follicular Helper T Cells As a Novel Cell Population Potentially Involved in the Pathogenesis of Rheumatoid Arthritis

    Sharon Ing1, Anika Alarakhia1, Elvira Lindwall1, Austin Fraser1, Jerald M. Zakem1, William E. Davis1, Tamika A. Webb-Detiege1, Robert Quinet1 and Xin Zhang2, 1Rheumatology, Ochsner Medical Center, New Orleans, LA, 2Institute of Translational Research, Ochsner Medical Center, New Orleans, LA

    Background/Purpose: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovium, causing progressive joint destruction and reduction in quality of life…
  • Abstract Number: 407 • 2012 ACR/ARHP Annual Meeting

    The I50V IL4R SNP Is Associated with Increased Th17 Cell Frequency and Poor Clinical Outcome in Rheumatoid Arthritis

    Jan Leipe1, Iryna Prots2, Markus A. Schramm1, Matthias Witt1, Axel P. Nigg1, Christiane S. Reindl1, Claudia Dechant1, Mathias Grunke1, Hendrik Schulze-Koops1 and Alla Skapenko3, 1Division of Rheumatology and Clinical Immunology, Med. Klinik und Poliklinik IV, University of Munich, Munich, Germany, 2Friedrich-Alexander-University Erlangen-Nürnberg, Junior Research Group III, Interdisciplinary Center for Clinical Research Nikolaus-Fiebiger Center for Molecular Medicine, Erlangen, 3Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany

    Background/Purpose: A single nucleotide polymorphism (SNP) in the IL4R gene (I50V, rs 1805010) has previously been associated with an aggressive destructive course of rheumatoid arthritis…
  • Abstract Number: 2334 • 2012 ACR/ARHP Annual Meeting

    T-Cell Cross Reactivity with Citrullinated Antigen and P. Gingivalis Membrane Antigen Following Infection with P. Gingavalis and/or Injection of Citrullinated Mouse Type II Collagen in DBA/1J Mice

    Michael J. Duryee1, Anand Dusad2, Carlos D. Hunter1, Ke Ren3, Dong Wang4, James R. O'Dell5, Lynell W. Klassen5, Ted R. Mikuls6 and Geoffrey M. Thiele7, 1Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 4Pharmaceutical Sciences, Univ of Nebraska Medical Ctr, Omaha, NE, 5Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE

    Background/Purpose: Recently, periodontal disease (PD) has been associated with the risk and progression of RA.  Patients with RA complicated by PD have been shown to…
  • Abstract Number: 2293 • 2012 ACR/ARHP Annual Meeting

    Interleukin-17A Positive Cells Are Increased in Systemic Sclerosis Skin and Their Number Is Inversely Correlated to Skin Thickness

    Marie-Elise Truchetet1, Nicolò Costantino Brembilla1, Elisa Montanari1, Paola Lonati2, Pier Luigi Meroni3 and Carlo Chizzolini1, 1University hospital of Geneva, Geneva, Switzerland, 2Division of Rheumatology, Istituto G. Pini, University of Milan, Milan, Italy, 3Division of Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy

    Background/Purpose: T cell producing IL-17A are increased in the peripheral blood of individuals affected by systemic sclerosis (SSc). We asked the question whether IL-17A-producing cells…
  • Abstract Number: 1175 • 2012 ACR/ARHP Annual Meeting

    Decreased Frequency of Th17 Cells in Early Rheumatoid Arthritis

    Irene Arroyo-Villa1, M. Belén Bautista-Caro1, Alejandro Balsa2, Pilar Aguado2, Laura Nuño2, Gema Bonilla3, Amaya Puig-Kröger4, Emilio Martín-Mola2 and M. Eugenia Miranda-Carús2, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Hospital La Paz-IdiPaz, Madrid, Spain, 3Rheumatology, Hospital La Paz, Madrid, Spain, 4Immuno-oncology, Hospital Gregorio Marañon, Madrid, Spain

    Background/Purpose: Our objective was to examine the frequency and phenotype of Th17 cells in the peripheral blood of early RA (eRA) patients. Methods: CD4+ T…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 32
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology